Stockholders' Equity - Narrative (Details) - USD ($) $ in Thousands			3 Months Ended	10 Months Ended	99 Months Ended
	Jun. 30, 2015	Nov. 14, 2013	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2024	Jun. 05, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)			0
Exercises in period, intrinsic value			$ 3,685
Restricted Stock Units and Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost not yet recognized, non-option			$ 278,884	$ 278,884	$ 278,884
Compensation cost not yet recognized, period for recognition			2 years 8 months 19 days
The 2013 Omnibus Equity Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)		5,713,899
Vesting period (in years)		4 years
Granted (in shares)				0
Capital shares reserved for future issuance, annual increase, maximum (in shares)			27,579,672	27,579,672	27,579,672
Shares available for grant (in shares)			0	0	0
Polyrize Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)			0	0	0
2023 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)						5,500,000
2015 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum employee subscription rate	15.00%
Purchase price of common stock, percent	85.00%
Number of shares authorized (in shares)	1,500,000
Percent of shares increase, employee stock purchase plan	1.00%
Common stock availability threshold, Employee Stock Purchase Plan	2.00%
Shares increase threshold, employee stock purchase plan (in shares)	1,200,000
Number of additional shares authorized (in shares)					3,908,910